A cost-minimization analysis of phenytoin versus levetiracetam for early seizure pharmacoprophylaxis after traumatic brain injury

Journal of Trauma and Acute Care Surgery

Volumn 72, Issue 1, 2012, Pages 276-281

  Pieracci, Fredric M ^a   Moore, Ernest E ^a   Beauchamp, Kathryn ^a   Tebockhorst, Seth ^a   Barnett, Carlton C ^a   Bensard, Denis D ^a   Burlew, Clay C ^a   Biffl, Walter L ^a   Stoval, Robert T ^a   Johnson, Jeffrey L ^a  

^a DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Cost effectiveness; Outcomes; Pharmacoeconomics; Seizures; Traumatic brain injury

Indexed keywords

ETIRACETAM; PHENYTOIN; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; PIRACETAM;

ANEMIA; COMPARATIVE EFFECTIVENESS; CONFERENCE PAPER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DRUG COST; DRUG EFFICACY; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HOSPITAL CHARGE; HUMAN; LABORATORY TEST; MENTAL DETERIORATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEIZURE; TRAUMATIC BRAIN INJURY; ADULT; ARTICLE; BRAIN INJURY; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DECISION TREE; ECONOMICS; METHODOLOGY; MONTE CARLO METHOD; STATISTICS;

ADULT; ANTICONVULSANTS; BRAIN INJURIES; COST CONTROL; COST-BENEFIT ANALYSIS; DECISION TREES; DRUG COSTS; HUMANS; MONTE CARLO METHOD; PHENYTOIN; PIRACETAM; SEIZURES;

EID: 84859646703     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e31823df31f     Document Type: Conference Paper

References (20)

1. Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med. 1990;323:497-502.
2. Pechadre JC, Lauxerois M, Colnet G, et al. [Prevention of late posttraumatic epilepsy by phenytoin in severe brain injuries. 2 years' follow-up.] Presse Med. 1991;20:841-845.
3. Vespa PM, Nuwer MR, Nenov V, et al. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg. 1999;91:750-760.
4. Claassen J, Jette N, Chum F, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007;69:1356-1365.
5. Kilpatrick CJ, Davis SM, Hopper JL, Rossiter SC. Early seizures after acute stroke. Risk of late seizures. Arch Neurol. 1992;49:509-511.
6. So EL, Annegers JF, Hauser WA, O'Brien PC, Whisnant JP. Populationbased study of seizure disorders after cerebral infarction. Neurology. 1996;46:350-355.
7. Schierhout G, Roberts I. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database Syst Rev. 2001;4:CD000173.
8. Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS/CNS; Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. XIII. Antiseizure prophylaxis. J Neurotrauma. 2007;24(suppl 1):S83-S86.
9. Chang BS, Lowenstein DH; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003;60:10-16.
10. Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care. 2010;12:165-172.
11. Jones KE, Puccio AM, Harshman KJ, et al. Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurg Focus. 2008;25:E3.
12. Lim DA, Tarapore P, Chang E, et al. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neurooncol. 2009;93:349-354.
13. Shah D, Husain AM. Utility of levetiracetam in patients with subarachnoid hemorrhage. Seizure. 2009;18:676-679.
14. Merrell RT, Anderson SK, Meyer FB, Lachance DH. Seizures in patients with glioma treated with phenytoin and levetiracetam. J Neurosurg. 2010;113:1176-1181.
15. Drummond MF. Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. Oxford, New York: Oxford Medical Publications, Oxford University Press; 1997:305.
16. Wang H, Gao J, Lassiter TF, et al. Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage. Neurocrit Care. 2006;5:71-78.
17. Rekling JC. Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation. Neurosci Lett. 2003;335:167-170.
18. Rutland-Brown W, Langlois JA, Thomas KE, Xi YL. Incidence of traumatic brain injury in the United States, 2003. J Head Trauma Rehabil. 2006;21:544-548.
19. Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil. 1999;14:602-615.
20. Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology. 2005;64:1134-1138.